Business Context and Reporting Period
This Form 8-K reports on the 2020 Annual Meeting of Stockholders held by Salesforce, Inc. on June 11, 2020. The filing details the voting results for director elections, equity plan amendments, auditor ratification, executive compensation approval, and a stockholder proposal.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material changes reported are the stockholder approvals of the following:
- Equity Incentive Plan: Amendment to the 2013 Equity Incentive Plan to increase authorized shares for grant by 31.5 million.
- Employee Stock Purchase Plan: Amendment to the 2004 Employee Stock Purchase Plan to increase authorized shares for employee purchase by 10 million.
- Director Elections: Re-election of all 11 director nominees, including Marc Benioff, Craig Conway, and Susan Wojcicki.
- Auditor Ratification: Ratification of Ernst & Young LLP as the independent auditor for fiscal 2021.
- Executive Compensation: Advisory approval of fiscal 2020 named executive officer compensation.
Outlook, Risks, and Unusual Items
Stockholder Proposal: A stockholder proposal requesting the ability of stockholders to act by written consent was defeated. It received approximately 28% of the votes cast (196 million for vs. 507 million against).
Management Commentary: The filing references the 2020 Proxy Statement for detailed descriptions of the amended plans and does not provide new management commentary or forward-looking guidance within this specific text.
Investor Verification Checklist
- Verify the specific terms of the Amended 2013 Equity Incentive Plan and 2004 ESPP in the referenced Exhibits 10.1 and 10.2.
- Review the 2020 Proxy Statement for the full context of the director elections and executive compensation advisory vote.
- Confirm the impact of the 31.5 million and 10 million share increases on future dilution.
- Note that the stockholder proposal for written consent was rejected, maintaining the current requirement for annual meetings for such actions.